{"cdcTestId":"2013-0474","testcaseName":"Dose 1 to dose 3 interval 16 weeks -5 days","vaccineGroup":"HPV","evaluationTestType":"Interval: Below Absolute Minimum","forecastTestType":"Recommended based on minimum interval from invalid dose","assessmentDate":"2008-08-07T00:00:00","patient":{"dob":"1996-03-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2008-04-18T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-05-16T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-07-31T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"3","earliestDate":"2008-10-23T00:00:00","recommendedDate":"2008-10-23T00:00:00","pastDueDate":"2009-06-14T00:00:00"},"doses":[{"dateAdministered":"2008-04-18T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-05-16T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-07-31T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2019-08-21T07:59:43.96","generalDescription":"This test case describes when the third dose of the HPV vaccine is administered at 16 weeks - 5 days from target dose #1, that a repeat dose of the vaccine should be give 12 weeks later.","changedInVersion":"4.1","reasonForChange":"V4.1: Updated to meet ACIP recommendation concerning the 4 day grace period for the third dose prior to December 16.2016. \nV3.2: Updated to reflect current ACIP recommendations for forecasting of the earliest and recommended date which is set by 12 weeks from invalid dose."}